Andrew is Professor of Human Psychopharmacology based in Melbourne, Australia and Newcastle-upon-Tyne, UK. He has led more than 100 clinical trials into the neurocognitive effects of nutritional interventions (whole diets, food components and specific nutrients). He has published >300 papers, been awarded >$25 million in research funding and has advised the UK and Canadian government on brain health. His current research focuses on understanding the mechanisms of cognitive impairment, enhancement and neuroprotection. Andrew is CSO of Arepa Nootropics and works closely with industry to allow rapid translation of research into evidence-based, end-user benefits to brain health.